Track topics on Twitter Track topics that are important to you
Proteomics is the study of structure and functions of proteins. After the advent of genomics and transcriptomics, proteomics was the next step in the study of biological systems. It is a complex study when compared to genomics, as an organism39;s genome is constant, while the proteome differs with cells and time.nnThe proteomics market has experienced a striking growth in the past few years as these have been found to be extremely beneficial in the diagnosis of diseases and identification of potential new drugs for the treatment of diseases. Factors such as the rise in focus of the key players, increase in Ramp;D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are set to drive the market. However, stringent regulatory approvals, high cost of the instruments, and dearth of qualified researchers are expected to restrain the growth of the market. The global proteomics market is expected to reach $44,452 million by 2022 from $17,988 million in 2015 at a CAGR of 13.7%nnThe global proteomics market is segmented into instruments, reagents, and services. Based on technology, the instruments segment is further divided into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, Xray crystallography, and protein fractionation systems. In the year 2015, protein microarrays accounted for the highest market share of instruments markets followed by spectrometry. In the reagents segment, immunoassays dominated the market in 2015, followed by spectroscopy and microarray reagents. On the basis of applications, the market is segmented in drug discovery, disease diagnosis, and others. Drug discovery was the largest application of proteomics in 2015. Geographically, the market is divided into North America, Europe, AsiaPacific, and LAMEA. In the year 2015, North America accounted for highest market share, owing to higher popularity of the technology, high cost of instruments, and high funding from the government and organizations such as National Institutes of Health NIH and National Science Foundation NSF. AsiaPacific is expected to witness fastest growth rate during the study period, owing to increase in government and corporate funding for Ramp;D.nnOver the past few years, the most important strategy followed by the leading companies was mergers amp; acquisitions. For instance, Thermo Fisher Scientific acquired Affymetrix Inc. May 2016, and Life Technologies February 2014 and Merck amp; Co., Inc. acquired SigmaAldrich November 2015.nnKEY MARKET BENEFITS:nnnnThe study provides an indepth analysis of the global proteomics market with current trends and future estimations to elucidate the imminent investment pockets.nnThe report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.nnExtensive analysis by components helps understand the various types of instruments used.nnCompetitive intelligence highlights the business practices followed by leading players across various regions.nnComprehensive analysis of all geographic regions is provided to determine the prevailing opportunities in these geographies.nnKey market players are profiled in the report and their strategies are analyzed thoroughly, which interpret the competitive outlook of the global market.nnExtensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.nnnKEY MARKET SEGMENTS:nnBy ComponentsnnnnInstrumentsnnnnnnProtein MicroarraynnnnnnnnSpectrometrynnnnMass SpectrometrynnnnnnnnnNMR SpectroscopynnnnnnnChromatographynnnnHPLC SystemsnnnnIon ChromatographynnnnAffinity ChromatographynnnnSupercritical Fluid ChromatographynnnnnnnnnElectrophoresisnnnnnnnGel ElectrophoresisnnnnCapillary ElectrophoresisnnnnnnnnnSurface Plasmon ResonancennnXray CrystallographynnnProtein Fractionation SystemsnnnnnnReagentsnnnnnMicroarraynnnSpectroscopynnnXRay CrystallographynnnChromatographynnnElectrophoresisnnnImmunoassaynnnProtein Fractionation ReagentsnnnnnnServices MarketnnnBy ApplicationnnnnDrug DiscoverynnDisease DiagnosisnnOthersnnnBy GeographynnnnNorth AmericannnnnnU.S.nnnCanadannnMexiconnnnnnEuropennnnnGermanynnnFrancennnUKnnnItalynnnSpainnnnRest of EuropennnnnnAsiaPacificnnnnnJapannnnChinannnIndiannnSouth KoreannnAustraliannnRest of AsiaPacificnnnnnnLAMEAnnnnnBrazilnnnIsraelnnnSouth AfricannnSaudi ArabiannnRest of LAMEAnnnnnnnKey players profiled in the reportnnnnThermo Fisher Scientific CorporationnnAgilent TechnologiesnnLuminex CorporationnnDanaher CorporationnnBioRad Laboratories, Inc.nnGE Healthcare,nnWaters Corporation,nnPerkinElmer, Inc.nnBruker CorporationnnCaprion Proteomics Inc.nnnOther companies in the value chain profiles not includednnnnQuanterix CorporationnnCourtagen Life Sciences, Inc.nnSera Prognostics, Inc.nnApplied Proteomics, Inc.nnMRM Proteomics, Inc.nnSonata Biosciences, Inc.nnApplied Biomics, Inc.nnAntigen Discovery, Inc.nnBionexus, Inc.nnCorrelia Biosystems, Inc.nnDigilab, Inc.nnGenScript CorporationnnCreative BiogenennProteome Sciencesn
Original Article: Global Proteomics Market by Products and Services Instruments, Reagents, and Services, by Application Drug Discovery and Disease Diagnosis Global Opportunity Analysis and Industry Forecast, 20142022 [Report Updated: 28112016] Prices from USD $5370NEXT ARTICLE
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...